Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06193577

Effect of Phaseolus Vulgaris L. Dry Extract on the Modulation of Weight and Metabolic Parameters

Single-centre, Prospective, Randomized, Placebo-controlled, Single-blind Clinical Trial to Evaluate the Efficacy of a Food Supplement Based on Phaseolus Vulgaris L. Dry Extract on the Modulation of Weight and Metabolic Parameters

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
IBSA Farmaceutici Italia Srl · Industry
Sex
Male
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Evaluation of the efficacy of Phaseolus vulgaris L. dry extract on weight modulation.

Detailed description

Monocentric, prospective, randomized, single-blind clinical trial to evaluate the effects of Phaseolus vulgaris L. dry extract (test) on weight reduction and on metabolic parameters after 12 weeks of supplementation. The efficacy on weight reduction will be evaluated in comparison with the placebo group (control).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPhaseolus Vulgaris L. Dry ExtractExtracts of Phaseolus vulgaris (beans) in association with a balanced diet are known to reduce glycaemia and food intake in rodents and humans thus promoting weight loss.
DIETARY_SUPPLEMENTPlaceboThe placebo control does not contain active ingredients.

Timeline

Start date
2023-11-08
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2024-01-05
Last updated
2025-01-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06193577. Inclusion in this directory is not an endorsement.